McCombe William D. 4
4 · Cytek Biosciences, Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
McCombe William D.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-04+330,882→ 330,882 totalExercise: $4.31Exp: 2035-03-04→ Common Stock (330,882 underlying) - Award
Restricted Stock Units
2025-03-04+208,816→ 208,816 total→ Common Stock (208,816 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest over 4 years with 1/48 of the total shares underlying the option vesting on April 4, 2025 and each month thereafter until fully vested.
- [F2]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2026 and each March 10 thereafter, until fully vested.